Related Experiment Video
Updated: May 10, 2026

18:57
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
A Molecular Communication System Model for Particulate Drug Delivery Systems
IEEE Transactions on Bio-Medical Engineering
|June 29, 2013
Summary
This study introduces molecular communication (MC) to model drug delivery systems (DDS). This approach analyzes drug particle transport for more effective and less invasive targeted therapies.
Area of Science:
- Biomedical Engineering
- Communication Systems
- Pharmacology
Background:
- Drug delivery systems (DDS) aim for targeted medication delivery, minimizing off-target effects.
- Particulate DDS utilize micro- or nano-sized particles to overcome biological barriers.
- Molecular Communication (MC) offers a novel framework for analyzing particle propagation in biological systems.
Purpose of the Study:
- To model particulate drug delivery systems using the principles of molecular communication.
- To develop analytical models for cardiovascular transport and drug propagation.
- To enable the design and optimization of advanced drug delivery strategies.
Main Methods:
- Abstracting drug particle propagation as a molecular communication channel.
- Developing a cardiovascular network model to compute blood velocity profiles.
- Creating a drug propagation network model for analytical drug delivery rate calculations.
Main Results:
- The study presents a novel model integrating cardiovascular dynamics and drug propagation.
- Analytical expressions for blood velocity and drug delivery rates were derived.
- Numerical results demonstrate the model's flexibility and accuracy in simulating DDS.
Conclusions:
- The developed MC model provides a powerful tool for analyzing and designing particulate DDS.
- This framework facilitates the optimization of drug delivery for enhanced efficacy and reduced invasiveness.
- The research opens avenues for novel communication techniques within Intrabody communication networks.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
